NEW DELHI, NOVEMBER-07-2019: The US Food and Drug Administration (FDA) has approved Sandoz’ biosimilar Ziextenzo (pegfilgrastim-bmez). The biosimilar pegfilgrastim has been…
Mumbai, June 01, 2019: In a cloud of an organised healthcare ecosystem, the demand for speciality chemicals and pharmaceutical products…
New Delhi, March 29, 2018: Management teams were generally optimistic on the outlook for domestic Indian markets, with sales growth…